Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.49B
Enterprise Value6.15B
P/E Ratio28.46
PEG Ratio-0.54
Price/Sales Ratio0.66
Price/Book Ratio1
Enterprise/Revenue1.25
Enterprise/EBITDA12

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue4.19B
Revenue/Share15.95
Gross Profit629.45M
EBITDA619.56M
Net Income200.3M
Diluted EPS0.66

Balance Sheet

Total Cash1.52B
Total Cash/Share5.04
Total Debt3.83B
Total Debt/Equity1.2
Current Ratio1.36
Book Value Per Share10.67

Price History

52-Week Change-41.24
52-Week High19.44
52-Week Low9.97
Moving Average 50 Days11.42
Moving Average 200 Days13.82

Statistics

Average Volume8.12M
Shares Outstanding300.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4.75
Payout Ratio1.14
Last Split Factor13:10
Last Split DateMay 28, 2024
AD